Mirae Asset Global Etfs Holdings Ltd. Maxcyte, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 57,345 shares of MXCT stock, worth $207,015. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,345
Previous 43,929
30.54%
Holding current value
$207,015
Previous $172,000
29.65%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$29.6 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$29.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$20.8 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$18.2 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$17.4 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $367M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...